Diagnostic imaging company Radnet has acquired AI ultrasound imaging company See-Mode Technologies through its wholly owned subsidiary, DeepHealth.
AI-powered ultrasound detection, characterization and reporting applications for the thyroid and breast will be integrated into Radnet’s Deephealth Population Health.
According to Radnet, the original application of See mode for detecting and characterizing thyroid nodule and breast lesions in ultrasound imaging: “Improve diagnostic accuracy and enhance clinical workflow by generating standardized reports.”
“Early deployment across parts of See-Mode’s FDA-approved thyroid ultrasound AI imaging centres has demonstrated that scanning times have been reduced by up to 30%, resulting in improved workflow efficiency with automatic See-Mode detection and reporting.
“If demand exceeds the reserved slots available for many of the ultrasound units with over 900 demand, the increased capacity created by See-Mode technology should improve our ability to increase better access and revenue through Radnet’s existing centres.”
Bigger trends
2024, GE Healthcare And deephealth Working together on AI imaging technology, we have further increased the innovation, commercialization and adoption of AI in imaging.
As part of the collaboration, the company said it will jointly develop smart technology solutions that leverage the power of AI to address obstacles across the imaging value chain, including efficiency in imaging interpretation and reporting and promoting collaboration across care teams.
Volpara Health Technologies 2022 I signed a usage agreement It is located throughout Radnet’s 353 imaging centers in seven US states using Radnet for the deployment of Volpara Analytics and Volpara Risk Pathways software. In 2024, SEE mode was acquired 510(k) clearance Provides AI-powered products from the FDA to detect and diagnose thyroid problems with ultrasound scans.
A year ago I got SEE mode Regulation approval Australia and New Zealand offer AI-powered breast and thyroid ultrasound products.